Steve Valiquette
Stock Analyst at Barclays
(1.85)
# 3,098
Out of 4,876 analysts
175
Total ratings
45.13%
Success rate
-3.56%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7 → $7.5 | $6.90 | +8.70% | 4 | Apr 16, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $8.41 | +42.69% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.45 | -30.13% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $725.78 | -15.13% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.90 | +83.67% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.74 | +33.69% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.46 | +124.22% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $15.76 | +52.28% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $68.49 | +25.57% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $53.99 | +57.44% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $300 | $379.30 | -20.91% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $97.92 | -10.13% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $34.51 | -1.48% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $173.63 | -39.53% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $62.88 | -12.53% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.26 | -28.81% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $178.08 | -20.26% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $25.16 | -80.13% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $122.20 | -53.36% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $152.13 | -46.10% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.36 | +3.69% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $36.58 | -15.25% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $297.05 | +26.24% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $30.60 | -37.91% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $241.88 | +135.65% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $167.18 | -61.72% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $326.31 | -5.00% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $309.11 | +82.78% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $5.70 | +1,215.79% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $3.92 | +384.69% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.39 | +194.99% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $21.61 | +57.33% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $5.02 | +298.41% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $102.86 | +152.77% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Apr 16, 2025
Maintains: Equal-Weight
Price Target: $7 → $7.5
Current: $6.90
Upside: +8.70%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $8.41
Upside: +42.69%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.45
Upside: -30.13%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $725.78
Upside: -15.13%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.90
Upside: +83.67%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.74
Upside: +33.69%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.46
Upside: +124.22%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $15.76
Upside: +52.28%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $68.49
Upside: +25.57%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $53.99
Upside: +57.44%
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $379.30
Upside: -20.91%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $97.92
Upside: -10.13%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $34.51
Upside: -1.48%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $173.63
Upside: -39.53%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $62.88
Upside: -12.53%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.26
Upside: -28.81%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $178.08
Upside: -20.26%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $25.16
Upside: -80.13%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $122.20
Upside: -53.36%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $152.13
Upside: -46.10%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $17.36
Upside: +3.69%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $36.58
Upside: -15.25%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $297.05
Upside: +26.24%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $30.60
Upside: -37.91%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $241.88
Upside: +135.65%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $167.18
Upside: -61.72%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $326.31
Upside: -5.00%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $309.11
Upside: +82.78%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $5.70
Upside: +1,215.79%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $3.92
Upside: +384.69%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.39
Upside: +194.99%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $21.61
Upside: +57.33%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $5.02
Upside: +298.41%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $102.86
Upside: +152.77%